Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stam, H.
Right arrow Articles by Versprille, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stam, H.
Right arrow Articles by Versprille, A.
(Chest. 2000;117:752-757.)
© 2000 American College of Chest Physicians

Evaluation of Diffusing Capacity in Patients With a Restrictive Lung Disease*

Henk Stam, PhD; Ted A. W. Splinter, PhD, MD and Adrian Versprille, PhD

* From the Pathophysiology Laboratory of the Department of Pulmonary Diseases (Drs. Stam and Versprille), Erasmus University; and the Department of Medical Oncology (Dr. Splinter), University Hospital Dijkzigt, Rotterdam, The Netherlands.

Correspondence to: Henk Stam, Phd, Lung Function Department, University Hospital Rotterdam, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands

Background: In healthy volunteers, the single-breath diffusing capacity of the lung for carbon monoxide (DLCO) decreases and DLCO normalized per liter alveolar volume (VA; DLCO/VA) increases if VA is decreased. We hypothesized that comparison of DLCO/VA with its predicted value at predicted total lung capacity (TLC) will result in an underestimation of the diffusion disorder in patients with a restrictive lung disease, if a similar relationship exists between DLCO/VA and lung volume as found in healthy volunteers.

Objective: To test this hypothesis, we studied total gas transfer DLCO and DLCO/VA as functions of VA in patients who developed a restrictive lung disease and a diffusion disorder in a short period of time.

Design: An observational survey.

Setting: Pulmonary function department.

Patients: Thirteen patients without any initial pulmonary pathology who developed the mentioned pulmonary pathology due to bleomycin treatment.

Interventions: Bleomycin treatment.

Measurements and results: We performed the single-breath test at various VA levels before, during, and after bleomycin treatment. In the majority of the patients, the DLCO vs VA relationship remained parabolic, but shifted downwards during therapy. Therefore, the linear DLCO/VA vs VA relationship shifted downwards, while the negative slope was not changed, indicating the development of a decreased gas transfer. Six patients also developed a volume restriction.

Conclusions: The agreement of the data with the hypothesis increased its probability. Consequently, to evaluate a diffusion disorder, DLCO/VA at a lower actual TLC of patients with a lung restriction should be compared to a reference DLCO/VA at a lung volume equal to the actual TLC.

Key Words: alveolar volume • bleomycin • chemotherapy • diffusing capacity • restrictive lung disease




This article has been cited by other articles:


Home page
Eur Respir JHome page
R. Pellegrino, G. Viegi, V. Brusasco, R. O. Crapo, F. Burgos, R. Casaburi, A. Coates, C. P. M. van der Grinten, P. Gustafsson, J. Hankinson, et al.
Interpretative strategies for lung function tests
Eur. Respir. J., November 1, 2005; 26(5): 948 - 968.
[Full Text] [PDF]


Home page
Eur Respir JHome page
N. MacIntyre, R. O. Crapo, G. Viegi, D. C. Johnson, C. P. M. van der Grinten, V. Brusasco, F. Burgos, R. Casaburi, A. Coates, P. Enright, et al.
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
Eur. Respir. J., October 1, 2005; 26(4): 720 - 735.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. W. Terheggen-Lagro, M. W. Bink, H. J. Vreman, and C. K. van der Ent
End-Tidal Carbon Monoxide Corrected for Lung Volume Is Elevated in Patients with Cystic Fibrosis
Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1227 - 1231.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
J.E. Cotes
Carbon monoxide transfer coefficient KCO (TL/VA): a flawed index
Eur. Respir. J., November 1, 2001; 18(5): 893 - 898.
[Full Text] [PDF]


Home page
Eur Respir JHome page
J.M.B. Hughes and N.B. Pride
In defence of the carbon monoxide transfer coefficient KCO (TL/VA)
Eur. Respir. J., February 1, 2001; 17(2): 168 - 174.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.